BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 6338896)

  • 1. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies.
    Barcos M; Minowada J; Minato K; Pollard C; Cancino M; Han T; Henderson E; Ozer H
    Leuk Res; 1983; 7(4):523-37. PubMed ID: 6604849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathology of non-Hodgkin lymphomas.
    Huber H; Gattringer C; Knapp W; Stein H
    Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody studies in B-cell chronic lymphocytic leukemia and allied disorders.
    Aisenberg AC; Wilkes BM
    Hematol Oncol; 1983; 1(1):13-9. PubMed ID: 6610619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of peanut lectin to germinal-centre cells: a marker for B-cell subsets of follicular lymphoma?
    Rose ML; Habeshaw JA; Kennedy R; Sloane J; Wiltshaw E; Davies AJ
    Br J Cancer; 1981 Jul; 44(1):68-74. PubMed ID: 6789856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIg-E- ("null-cell") non-Hodgkin's lymphomas. Multiparametric determination of their B- or T-cell lineage.
    Knowles DM; Dodson L; Burke JS; Wang JM; Bonetti F; Pelicci PG; Flug F; Dalla-Favera R; Wang CY
    Am J Pathol; 1985 Sep; 120(3):356-70. PubMed ID: 2931028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ immunologic characterization of follicular lymphomas.
    Ancelin E; Delsol G; Familiades J; Mason DY; Kuhlein E; Al Saati T; Laurent G; Huguet-Rigal F
    Hematol Oncol; 1984; 2(3):221-37. PubMed ID: 6384007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune marker expression in 53 lymphomas of high-grade malignancy.
    Pallesen G; Madsen M; Schifter S
    Histopathology; 1983 Nov; 7(6):841-57. PubMed ID: 6689315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of large-cell lymphomas using monoclonal and heterologous antibodies.
    van der Valk P; van den Besselaar-Dingjan G; Daha MR; Meijer CJ
    J Clin Pathol; 1983 Jan; 36(1):44-50. PubMed ID: 6337190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of immunological phenotypes of lymphoblastic lymphoma.
    Cossman J; Chused TM; Fisher RI; Magrath I; Bollum F; Jaffe ES
    Cancer Res; 1983 Sep; 43(9):4486-90. PubMed ID: 6191861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-associated immunoglobulin in human non-Hodgkin lymphomas. A comparative study of surface immunoglobulin on cells in suspension and cytoplasmic immunoglobulin by immunohistochemistry.
    Landaas TO; Godal T; Marton PF; Kvaløy S; Langholm R; Lindmo T; Jørgensen OG; Høst H
    Acta Pathol Microbiol Scand A; 1981 Mar; 89(2):91-101. PubMed ID: 7023187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin lymphomas.
    Porwit-Ksiazek A; Christensson B; Lindemalm C; Mellstedt H; Tribukait B; Biberfeld G; Biberfeld P
    Int J Cancer; 1983 Dec; 32(6):667-74. PubMed ID: 6317576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological study.
    Dorreen MS; Habeshaw JA; Stansfeld AG; Wrigley PF; Lister TA
    Br J Cancer; 1984 Apr; 49(4):465-76. PubMed ID: 6370286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
    Huber H; Gattringer C; Thaler J; Peschel C
    Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
    Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G
    Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets.
    Aisenberg AC; Bloch KJ; Wilkes BM
    J Exp Med; 1981 Nov; 154(5):1709-14. PubMed ID: 6975352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.